FDA Unleashes Fast Lane: Pilot Program Shortens Drug Testing Timelines

The FDA just launched Operation TrialBlazer, a pilot program that partners drugmakers with research institutions to slash the time it takes to begin human testing. The initiative, which opened applications Tuesday, aims to fix a staggering lag where U.S. drug pathways are measured in "years" while competitors like China and Australia move in "months." The program is part of a broader HHS push to reclaim American dominance in biotech innovation.

"Too often,...